Type 1 diabetes risk and severity after SARS-CoV-2 infection or vaccination

Data Availability

Data privacy legislation in Norway and Sweden does not allow the authors to share individual level patient data. Researchers can apply for similar data to the respective registry holders after ethics approval in the respective countries. Researchers can apply for access to the Norwegian population health registry data by application to https://helsedata.no/, and for access to data from the Norwegian Childhood Diabetes by sending an application to barnediabetes{at}ous-hf.no. The Swedish Medical Products Agency will consider proposals for research collaboration. Enquiries can be submitted to the Swedish Medicines Agency (registrator{at}lakemedelsverket.se and CC rickard.ljung{at}lakemedelsverket.se).